Autonomic modulation and health-related quality of life among schizophrenic patients treated with non-intensive case management
Journal
PLoS ONE
Journal Volume
6
Journal Issue
11
Date Issued
2011
Author(s)
Abstract
Background: Schizophrenia is associated with autonomic dysfunction and this may increase cardiovascular mortality. Past studies on autonomic modulation of schizophrenic patients focused on inpatients rather than individuals in a community setting, especially those receiving non-intensive case management (non-ICM). Besides, autonomic modulation and its association with health-related quality of life (HRQoL) in this population remain unexplored. Methods: A total of 25 schizophrenic patients treated by non-ICM and 40 healthy volunteers were matched by age, gender and body mass index; smokers were excluded. Between the two groups, we compared the individuals' 5 min resting assessments of heart rate variability and their HRQoL, which was measured using EuroQoL-5D (EQ-5D). Patients with schizophrenia were assessed for psychopathology using the Positive and Negative Syndrome Scale for Schizophrenia (PANSS). We examined the relationship between heart rate variability measurements, HRQoL scores, PANSS scores, and other clinical variables among the schizophrenic patients treated by non-ICM. Results: Compared to the controls, patients with schizophrenia showed a significant impairment of autonomic modulation and a worse HRQoL. Cardiovagal dysfunction among the schizophrenic patients could be predicted independently based on lower educational level and more negative symptoms. Sympathetic predominance was directly associated with anticholinergics use and EQ-5D using a visual analogue scale (EQ-VAS). Conclusion: Patients with schizophrenia treated by non-ICM show a significant impairment of their autonomic function and HRQoL compared to the controls. Since the sympathovagal dysfunction is associated with more negative symptoms or higher VAS score, the treatment of the negative symptoms as well as the monitoring of HRQoL might help to manage cardiovascular risk among these individuals. In addition, EQ-VAS scores must be interpreted more cautiously in such a population. ? 2011 Chang et al.
SDGs
Other Subjects
cholinergic receptor blocking agent; adult; article; autonomic dysfunction; cardiovascular risk; case management; clinical article; conservative treatment; controlled study; disease association; drug use; educational status; female; heart rate variability; human; male; negative syndrome; neuromodulation; non invasive procedure; patient assessment; Positive and Negative Syndrome Scale; prediction; quality of life; schizophrenia; visual analog scale; autonomic nervous system; case control study; middle aged; pathophysiology; schizophrenia; Adult; Autonomic Nervous System; Case Management; Case-Control Studies; Female; Humans; Male; Middle Aged; Quality of Life; Schizophrenia
Type
journal article